DOI: 10.1148/rg.273065130
RadioGraphics 2007;27:595-615
© RSNA, 2007
What Every Radiologist Should Know about Idiopathic Interstitial Pneumonias1
Christina Mueller-Mang, MD,
Claudia Grosse, MD,
Katharina Schmid, MD,
Leopold Stiebellehner, MD, and
Alexander A. Bankier, MD
1 From the Departments of Radiology (C.M.M., C.G., A.A.B.), Pathology (K.S.), and Pulmonology (L.S.), Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. Presented as an education exhibit at the 2005 RSNA Annual Meeting. Received July 12, 2006; revision requested October 25 and received November 27; accepted December 4. All authors have no financial relationships to disclose.
Address correspondence to C.M.M. (e-mail: christina.mueller-mang{at}meduniwien.ac.at).
 |
Abstract
|
|---|
The American Thoracic Society–European Respiratory Society classification of idiopathic interstitial pneumonias (IIPs), published in 2002, defines the morphologic patterns on which clinical-radiologic-pathologic diagnosis of IIPs is based. IIPs include seven entities: idiopathic pulmonary fibrosis, which is characterized by the morphologic pattern of usual interstitial pneumonia (UIP); nonspecific interstitial pneumonia (NSIP); cryptogenic organizing pneumonia (COP); respiratory bronchiolitis–associated interstitial lung disease (RB-ILD); desquamative interstitial pneumonia (DIP); lymphoid interstitial pneumonia (LIP); and acute interstitial pneumonia (AIP). The characteristic computed tomographic findings in UIP are predominantly basal and peripheral reticular opacities with honeycombing and traction bronchiectasis. In NSIP, basal ground-glass opacities tend to predominate over reticular opacities, with traction bronchiectasis only in advanced disease. COP is characterized by patchy peripheral or peribronchovascular consolidation. RB-ILD and DIP are smoking-related diseases characterized by centrilobular nodules and ground-glass opacities. LIP is characterized by ground-glass opacities, often in combination with cystic lesions. AIP manifests as diffuse lung consolidation with ground-glass opacities, which usually progress to fibrosis in patients who survive the acute phase of the disease. Correct diagnosis of IIPs can be achieved only by means of interdisciplinary consensus and stringent correlation of clinical, imaging, and pathologic findings.
© RSNA, 2007
|
LEARNING OBJECTIVES FOR TEST 1
|
|---|
After reading this article and taking the test, the reader will be able to:- List the seven entities included in the ATS-ERS classification of IIPs.
- Describe the morphologic patterns associated with the IIPs.
- Identify these patterns at high-resolution CT and interpret them in the appropriate clinicopathologic context.
|
Introduction
|
|---|
The diagnostic approach to idiopathic interstitial pneumonias (IIPs) has long been confusing because these disorders were categorized according to different clinical, radiologic, and histologic classifications (1,2).
In 2001, the American Thoracic Society (ATS) and European Respiratory Society (ERS) standardized the terminology for IIPs (Fig 1) (3). This new ATS-ERS classification is the result of a multidisciplinary consensus and includes seven disease entities: idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), cryptogenic organizing pneumonia (COP), respiratory bronchiolitis–associated interstitial lung disease (RB-ILD), desquamative interstitial pneumonia (DIP), lymphoid interstitial pneumonia (LIP), and acute interstitial pneumonia (AIP).
In their idiopathic form, IIPs are rare diseases. However, more frequent disorders such as sarcoidosis, vasculitis, and connective tissue diseases can display identical morphologic patterns, and the IIPs are considered "prototypes" for these morphologic alterations (3). Because imaging plays a crucial role in identifying both the idiopathic and the secondary interstitial pneumonias, radiologists need to be familiar with the morphologic and clinical manifestations and the diagnostic approach to these conditions.
The main clinical symptoms of IIPs are non-specific and consist of cough and dyspnea; however, other factors such as age, gender, risk factors, and course of disease can be helpful in distinguishing between the various entities (Table 1).
The classification of IIPs is based on histologic criteria, but each histologic pattern is associated with a characteristic computed tomography (CT) pattern that, provided an adequate CT technique is used, correlates well with histologic findings (Table 2) (3).
The key role that radiologists play in the work-up of IIPs necessitates a thorough knowledge of the patterns as described in the international classification and an increased awareness of the multidisciplinary challenges involved in their interpretation.
In this article, we illustrate the morphologic characteristics of the patterns included in the ATS-ERS classification of IIPs and present an encyclopedic review of the clinical and radiologic hallmarks associated with these patterns.
|
Idiopathic Pulmonary Fibrosis
|
|---|
IPF is the most common entity of the IIPs. By definition, IPF is the term for the clinical syndrome associated with the morphologic pattern of UIP (3). With a median survival time ranging from 2 to 4 years, IPF has a substantially poorer prognosis than NSIP, COP, RB-ILD, DIP, and LIP (3,4).
Clinical Features
The typical patient with IPF is 50 years old or older. Patients present with progressively worsening dyspnea and nonproductive cough (3). Many patients also report that the subtle onset of their symptoms months or even years earlier was mistaken for a less serious respiratory disease, which delayed referral to a specialized center (5). Although there are slightly more cases in men than in women, there is no obvious gender predilection (3). A history of cigarette smoking seems to be a risk factor for the development of IPF; however, it does not appear to affect the course of the disease (4,6,7). Usually, patients do not respond to high-dose corticosteroid therapy; data suggest that, due to the considerable side effects of corticosteroids, this therapy might even be contraindicated (8). However, a combination therapy of cyclosporin A and corticosteroids seems to be efficacious for acute exacerbations of IPF (9). In addition, patients should be considered candidates for lung transplantation early after diagnosis (10).
Histologic Features
The histologic hallmark of UIP is the presence of scattered fibroblastic foci (Fig 2). Typically, the lung involvement is heterogeneous and areas of normal lung alternate with interstitial inflammation and honeycombing (1). Owing to the patchy lung involvement, histologic evaluation of multiple biopsy specimens from one patient may reveal discordant histologic patterns. Evidence of the UIP pattern in one biopsy specimen is associated with a worse prognosis, independently of other coexisting patterns (11,12). Therefore, biopsy samples from more than one lobe should be obtained in any patient with suspected IIP, and high-resolution CT should serve as a guiding tool for determining the appropriate anatomic location of the biopsy site (12,13).
View larger version (183K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2a. Histologic features of UIP. (a) Photomicrograph (original magnification, x40; hematoxylin-eosin stain) shows patchy fibrosis with remodeling of the lung architecture. Interstitial chronic inflammation is mild, with only a few lymphoid aggregates (thin arrow). Cystically dilated airspaces that produce a honeycomb pattern (arrowhead) and areas of relatively unaffected lung (thick arrow) are present. (b) Photomicrograph (original magnification, x200; hematoxylin-eosin stain) shows a fibroblastic focus of loose organizing connective tissue (arrowheads), which is the hallmark of UIP.
|
|
View larger version (177K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2b. Histologic features of UIP. (a) Photomicrograph (original magnification, x40; hematoxylin-eosin stain) shows patchy fibrosis with remodeling of the lung architecture. Interstitial chronic inflammation is mild, with only a few lymphoid aggregates (thin arrow). Cystically dilated airspaces that produce a honeycomb pattern (arrowhead) and areas of relatively unaffected lung (thick arrow) are present. (b) Photomicrograph (original magnification, x200; hematoxylin-eosin stain) shows a fibroblastic focus of loose organizing connective tissue (arrowheads), which is the hallmark of UIP.
|
|
Imaging Features
The chest radiograph is normal in most patients with early disease. In advanced disease, the chest radiograph shows decreased lung volumes and subpleural reticular opacities that increase from the apex to the bases of the lungs (14).
This apicobasal gradient is even better seen on high-resolution CT images. Together with subpleural reticular opacities and macrocystic honeycombing combined with traction bronchiectasis, the apicobasal gradient represents a trio of signs that is highly suggestive of UIP (Fig 3) (15,16). Therefore, UIP should be considered in patients who present with low lung volumes, subpleural reticular opacities, macrocystic honeycombing, and traction bronchiectasis, the extent of which increases from the apex to the bases of the lungs (Fig 4). In the typical patient with UIP, the disease is most extensive on the most basal section of the high-resolution CT examination. Ground-glass opacities are present in the majority of patients with UIP but are usually limited in extent (17). Typically, imaging findings are heterogeneous, with areas of fibrosis alternating with areas of normal lung (Fig 5).
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3a. Distribution (a), CT image (b), and CT pattern (c) of UIP. The distribution is subpleural with an apicobasal gradient (red area in a). CT shows honeycombing (green areas in c), reticular opacities (blue areas in c), traction bronchiectasis (red area in c), and focal ground-glass opacity (gray area in c).
|
|
View larger version (122K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3b. Distribution (a), CT image (b), and CT pattern (c) of UIP. The distribution is subpleural with an apicobasal gradient (red area in a). CT shows honeycombing (green areas in c), reticular opacities (blue areas in c), traction bronchiectasis (red area in c), and focal ground-glass opacity (gray area in c).
|
|
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3c. Distribution (a), CT image (b), and CT pattern (c) of UIP. The distribution is subpleural with an apicobasal gradient (red area in a). CT shows honeycombing (green areas in c), reticular opacities (blue areas in c), traction bronchiectasis (red area in c), and focal ground-glass opacity (gray area in c).
|
|
View larger version (130K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4a. IPF in a 64-year-old man. (a) High-resolution CT image obtained at presentation shows reticular opacities, honeycombing (arrowhead), and focal ground-glass opacity (thick arrow). Moderate traction bronchiectasis is present (thin arrow). These findings are consistent with the UIP pattern. (b) Follow-up CT image obtained 12 months later shows marked progression of the honeycombing (arrowheads) and traction bronchiectasis (arrows).
|
|
View larger version (137K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4b. IPF in a 64-year-old man. (a) High-resolution CT image obtained at presentation shows reticular opacities, honeycombing (arrowhead), and focal ground-glass opacity (thick arrow). Moderate traction bronchiectasis is present (thin arrow). These findings are consistent with the UIP pattern. (b) Follow-up CT image obtained 12 months later shows marked progression of the honeycombing (arrowheads) and traction bronchiectasis (arrows).
|
|
View larger version (152K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5a. IPF in a 67-year-old man. (a) High-resolution CT image shows areas of relatively unaffected lung parenchyma with only ground-glass opacity (arrow) next to fibrotic areas with honeycombing and traction bronchiectasis (arrowhead), an appearance typical of UIP. (b) Coronal CT image shows an obvious apicobasal gradient of the lung alterations.
|
|
View larger version (167K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5b. IPF in a 67-year-old man. (a) High-resolution CT image shows areas of relatively unaffected lung parenchyma with only ground-glass opacity (arrow) next to fibrotic areas with honeycombing and traction bronchiectasis (arrowhead), an appearance typical of UIP. (b) Coronal CT image shows an obvious apicobasal gradient of the lung alterations.
|
|
In patients who show the characteristic distribution and high-resolution CT pattern of UIP and the appropriate clinical features, the diagnosis can be reliably made without biopsy (18,19). The ATS-ERS has defined eight major and minor criteria for the diagnosis of IPF in the absence of a surgical lung biopsy, which are summarized in Table 3. However, histologic confirmation should be obtained in all patients with atypical imaging findings, such as extensive ground-glass opacities, nodules, consolidation, or a predominantly peribronchovascular distribution (3,20).
|
Nonspecific Interstitial Pneumonia
|
|---|
NSIP is less common than UIP but is still one of the most common histologic findings in patients with IIPs (21). NSIP is associated with a variety of imaging and histologic findings, and the diagnostic approach is highly challenging. However, the distinction of NSIP from UIP is more than academic, given the better response to corticosteroids seen in a subgroup of patients with NSIP (22,23).
Owing to the clinical, radiologic, and pathologic variability of NSIP, the term should be considered a provisional diagnosis until further characterization of this entity has been established (3).
Clinical Features
The typical patient with NSIP is between 40 and 50 years old and is usually about a decade younger than the patient with IPF. Symptoms of NSIP are similar to those of IPF but usually milder (24). Patients present with gradually worsening dyspnea over several months, and they often experience fatigue and weight loss. There is no gender predilection, and cigarette smoking is not an obvious risk factor in the development of NSIP. Treatment of patients with NSIP is based on the use of systemic corticosteroids in combination with cytotoxic drugs, such as cyclophosphamide and cyclosporin, and the majority of patients stabilize or improve with this therapy (25).
Although it is primarily defined as an idiopathic disease, the morphologic pattern of NSIP is encountered in association with frequent disorders, such as connective tissue diseases, hypersensitivity pneumonitis, or drug exposure (26,27). Once the morphologic pattern of NSIP has been determined in a patient, these secondary forms of NSIP must be ruled out by the clinician.
Histologic Features
The histologic pattern of NSIP is characterized by temporally and spatially homogeneous lung involvement (28). This homogeneity is a key feature in differentiating the NSIP pattern from the UIP pattern. On the basis of the varying proportions of inflammation and fibrosis, NSIP is divided into cellular and fibrosing subtypes (Fig 6) (1). In cellular NSIP, the thickening of alveolar septa is primarily caused by inflammatory cells; in fibrosing NSIP, interstitial fibrosis is seen in addition to mild inflammation. Cellular NSIP is less common than fibrosing NSIP but shows a better response to corticosteroids and carries a substantially better prognosis (21). Histologic distinction between fibrotic NSIP and UIP is difficult and is subject to substantial interobserver variation (20). In borderline cases, CT correlation may help by showing features more typical of either UIP or NSIP.
View larger version (190K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 6a. Histologic features of NSIP. (a) Photomicrograph (original magnification, x100; hematoxylin-eosin stain) of cellular NSIP shows a uniform appearance of interstitial inflammation (arrow), which consists of lymphocytes and plasma cells. (b) Photomicrograph (original magnification, x100; hematoxylin-eosin stain) of fibrosing NSIP shows areas of fibrosis (arrow) in addition to uniform inflammation.
|
|
View larger version (158K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 6b. Histologic features of NSIP. (a) Photomicrograph (original magnification, x100; hematoxylin-eosin stain) of cellular NSIP shows a uniform appearance of interstitial inflammation (arrow), which consists of lymphocytes and plasma cells. (b) Photomicrograph (original magnification, x100; hematoxylin-eosin stain) of fibrosing NSIP shows areas of fibrosis (arrow) in addition to uniform inflammation.
|
|
Imaging Features
In patients with early NSIP, the chest radiograph is normal. In advanced disease, bilateral pulmonary infiltrates are the most salient abnormality. The lower lung lobes are more frequently involved, but an obvious apicobasal gradient, as seen in UIP, is usually missing (3).
High-resolution CT typically reveals a subpleural and rather symmetric distribution of lung abnormalities (Fig 7). The most common manifestation consists of patchy ground-glass opacities combined with irregular linear or reticular opacities and scattered micronodules (Fig 8) (29–31). In advanced disease, traction bronchiectasis and consolidation can be seen; however, ground-glass opacities remain the most obvious high-resolution CT feature in the typical patient with NSIP and are related to the histologic finding of homogeneous interstitial inflammation (29,30).
View larger version (51K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 7a. Distribution (a), CT image (b), and CT pattern (c) of NSIP. The distribution is subpleural with no obvious gradient (red area in a). CT shows ground-glass opacity (gray areas in c), irregular linear and reticular opacities (blue areas in c), micronodules (red areas in c), and microcystic honeycombing (green areas in c).
|
|
View larger version (144K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 7b. Distribution (a), CT image (b), and CT pattern (c) of NSIP. The distribution is subpleural with no obvious gradient (red area in a). CT shows ground-glass opacity (gray areas in c), irregular linear and reticular opacities (blue areas in c), micronodules (red areas in c), and microcystic honeycombing (green areas in c).
|
|
View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 7c. Distribution (a), CT image (b), and CT pattern (c) of NSIP. The distribution is subpleural with no obvious gradient (red area in a). CT shows ground-glass opacity (gray areas in c), irregular linear and reticular opacities (blue areas in c), micronodules (red areas in c), and microcystic honeycombing (green areas in c).
|
|
View larger version (147K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 8a. NSIP in a 60-year-old woman with mild dyspnea and fatigue. (a) High-resolution CT image of the lower lungs shows bilateral subpleural ground-glass opacities (arrowhead) and irregular linear opacities (arrow). The patient received corticosteroid treatment. (b) Follow-up CT image obtained 6 months later shows improvement, with partial resolution of the ground-glass opacities (arrowhead) and linear opacities (arrow).
|
|
View larger version (151K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 8b. NSIP in a 60-year-old woman with mild dyspnea and fatigue. (a) High-resolution CT image of the lower lungs shows bilateral subpleural ground-glass opacities (arrowhead) and irregular linear opacities (arrow). The patient received corticosteroid treatment. (b) Follow-up CT image obtained 6 months later shows improvement, with partial resolution of the ground-glass opacities (arrowhead) and linear opacities (arrow).
|
|
Other findings in advanced NSIP include subpleural cysts, but compared to those of UIP, these cysts are smaller and limited in extent (Fig 9) (29). The term "microcystic honeycombing" is used for these cystic changes in NSIP, as opposed to the macrocystic honeycombing seen in UIP (32,33). Although the CT features of cellular and fibrotic NSIP overlap considerably, it has been shown that honeycombing is seen almost exclusively in patients with fibrotic NSIP (17,29). Other CT findings that have been correlated with increased likelihood of fibrosis in NSIP are the extent of traction bronchiectasis and intralobular reticular opacities (29).
View larger version (141K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9a. NSIP in a 53-year-old man with mild dyspnea. (a) Coronal CT image shows diffuse lung involvement consisting of peripherally located irregular linear opacities with ground-glass opacities (arrows). Small cystic lesions are seen (arrowhead). (b) Axial high-resolution CT image shows the small cystic lesions more clearly (arrowhead).
|
|
View larger version (154K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9b. NSIP in a 53-year-old man with mild dyspnea. (a) Coronal CT image shows diffuse lung involvement consisting of peripherally located irregular linear opacities with ground-glass opacities (arrows). Small cystic lesions are seen (arrowhead). (b) Axial high-resolution CT image shows the small cystic lesions more clearly (arrowhead).
|
|
Owing to the substantial overlap of high-resolution CT patterns, the major CT differential diagnosis for NSIP is UIP. The key CT features that favor the diagnosis of NSIP over UIP are homogeneous lung involvement without an obvious apicobasal gradient, extensive ground-glass abnormalities, a finer reticular pattern, and micronodules (Figs 10, 11) (17,20,34). Follow-up CT also demonstrates differences between patients with NSIP and those with UIP. In patients with NSIP, ground-glass opacities usually do not progress to areas of honeycombing, even if there is associated bronchiectasis (30). However, in patients with UIP, progression of ground-glass attenuation to honeycombing is common and indicates irreversible fibrosis (35).
View larger version (173K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 11a. Comparison of high-resolution CT features between UIP and NSIP. (a) UIP is characterized by heterogeneous lung abnormalities consisting of subpleural honeycombing (arrowhead), reticular opacities, and traction bronchiectasis. (b) NSIP demonstrates homogeneous lung involvement with predominance of ground-glass opacity combined with sub-pleural linear opacities and micronodules. The microcysts in NSIP (arrowhead) are much smaller than the honeycombing in UIP.
|
|
View larger version (133K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 11b. Comparison of high-resolution CT features between UIP and NSIP. (a) UIP is characterized by heterogeneous lung abnormalities consisting of subpleural honeycombing (arrowhead), reticular opacities, and traction bronchiectasis. (b) NSIP demonstrates homogeneous lung involvement with predominance of ground-glass opacity combined with sub-pleural linear opacities and micronodules. The microcysts in NSIP (arrowhead) are much smaller than the honeycombing in UIP.
|
|
Despite differences in distribution and CT pattern, the differential diagnosis between UIP and NSIP remains challenging, and surgical lung biopsy is required in all patients who do not present with the typical clinical and CT features of UIP.
|
Cryptogenic Organizing Pneumonia
|
|---|
COP is an IIP with characteristic clinical and radiologic features. The histologic pattern of COP is organizing pneumonia, formerly referred to as bronchiolitis obliterans organizing pneumonia (BOOP). The term BOOP has been omitted to avoid confusion with airway diseases such as constrictive bronchiolitis (3).
Clinical Features
The typical patient with COP has a mean age of 55 years. Women and men are equally affected and present with mild dyspnea, cough, and fever that have been developing over a few weeks (36). Patients typically report a respiratory tract infection preceding their symptoms, and antibiotics were commonly prescribed at a previous consultation (37). There is no association with cigarette smoking; in fact, most patients are nonsmokers or ex-smokers (3). The majority of patients recover completely after administration of corticosteroids, but relapses occur frequently within 3 months after corticosteroid therapy is reduced or stopped (38). As with the other interstitial pneumonias, the pattern of organizing pneumonia may occur in a wide variety of entities, notably in collagen vascular diseases and in infectious and drug-induced lung diseases (26,27). Therefore, the final diagnosis of COP should be rendered only after exclusion of any other possible cause of organizing pneumonia.
Histologic Features
The histologic hallmark of organizing pneumonia is the presence of granulation tissue polyps in the alveolar ducts and alveoli (Fig 12) (39). These fibroblast proliferations result from organization of inflammatory intraalveolar exudates (36). Typically, there is patchy lung involvement with preservation of lung architecture. The granulation tissue is all the same age and contains few inflammatory cells.
View larger version (178K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12. Histologic features of COP. Photomicrograph (original magnification, x100; hematoxylin-eosin stain) shows polypoid fibroblastic foci in the alveolar ducts and alveoli (arrows). The organizing connective tissue is all the same age and shows moderate cellular proliferation.
|
|
Imaging Features
The chest radiograph in patients with COP usually shows unilateral or bilateral patchy consolidations that resemble pneumonic infiltrates (40). However, the consolidations in COP do not represent an active pneumonia but result from intraalveolar fibroblast proliferations, which may be associated with prior respiratory infection. Some patients present with nodular opacities on the chest radiograph. Lung volumes are preserved in most patients.
Frequently, the CT findings are far more extensive than expected from a review of the plain chest radiograph. The lung abnormalities show a characteristic peripheral or peribronchial distribution, and the lower lung lobes are more frequently involved (Figs 13, 14) (41). In some cases, the outermost subpleural area is spared (Fig 15) (42). Typically, the appearance of the lung opacities varies from ground glass to consolidation; in the latter, air bronchograms and mild cylindrical bronchial dilatation are a common finding (41). These opacities have a tendency to migrate, changing location and size, even without treatment (42). They are of variable size, ranging from a few centimeters to an entire lobe.
View larger version (14K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 13a. Distribution (a), CT image (b), and CT pattern (c) of COP. The distribution is peripheral or peribronchial with a basal predominance (red areas in a). CT shows consolidation with air bronchograms (dark gray areas in c), ground-glass opacities (light gray areas in c), linear opacities (blue areas in c), and mild bronchial dilatation (red areas in c).
|
|
View larger version (103K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 13b. Distribution (a), CT image (b), and CT pattern (c) of COP. The distribution is peripheral or peribronchial with a basal predominance (red areas in a). CT shows consolidation with air bronchograms (dark gray areas in c), ground-glass opacities (light gray areas in c), linear opacities (blue areas in c), and mild bronchial dilatation (red areas in c).
|
|
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 13c. Distribution (a), CT image (b), and CT pattern (c) of COP. The distribution is peripheral or peribronchial with a basal predominance (red areas in a). CT shows consolidation with air bronchograms (dark gray areas in c), ground-glass opacities (light gray areas in c), linear opacities (blue areas in c), and mild bronchial dilatation (red areas in c).
|
|
View larger version (150K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14a. COP in a 54-year-old woman. (a) Coronal CT image shows extensive bilateral peribronchial consolidation and ground-glass opacities (arrows). An endotracheal tube is present (arrowhead), indicating the need for mechanical ventilation. (b) CT image obtained after 3 weeks of corticosteroid and supportive treatment shows subtotal resolution of the lung abnormalities (arrows).
|
|
View larger version (138K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14b. COP in a 54-year-old woman. (a) Coronal CT image shows extensive bilateral peribronchial consolidation and ground-glass opacities (arrows). An endotracheal tube is present (arrowhead), indicating the need for mechanical ventilation. (b) CT image obtained after 3 weeks of corticosteroid and supportive treatment shows subtotal resolution of the lung abnormalities (arrows).
|
|
In the appropriate clinical context, that is, consolidation that increases over several weeks despite antibiotics, the CT features of COP are often suggestive. However, apart from the typical imaging pattern of COP, other less specific imaging patterns can be encountered. These atypical imaging findings include irregular linear opacities, solitary focal lesions that resemble lung cancer, or multiple nodules that may cavitate (Fig 16) (43–45). In either case, the diagnosis should be confirmed with surgical lung biopsy. The role of transbronchial lung biopsy for diagnosis of COP is currently under evaluation (3).
View larger version (113K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 16a. Atypical appearances of COP. (a) CT image shows bizarrely shaped nodules, some of which are cavitating (arrow). (b) CT image shows perilobular opacities that resemble thickened interlobular septa (arrow).
|
|
View larger version (118K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 16b. Atypical appearances of COP. (a) CT image shows bizarrely shaped nodules, some of which are cavitating (arrow). (b) CT image shows perilobular opacities that resemble thickened interlobular septa (arrow).
|
|
|
Respiratory Bronchiolitis–associated Interstitial Lung Disease
|
|---|
RB-ILD is a smoking-related interstitial lung disease and is thought to represent an exaggerated and symptomatic form of the histologically common and incidental finding of respiratory bronchiolitis. Because of the significant overlap in clinical, imaging, and histologic features between RB-ILD and DIP, these entities are considered a pathomorphologic continuum, representing different degrees of severity of the same disease process (46,47).
Clinical Features
Patients with RB-ILD are usually 30–40 years old and have an average smoking history of 30 pack-years (47). Men are affected nearly twice as often as women and present with mild dyspnea and cough. Smoking cessation is the most important component in the therapeutic management of RB-ILD. However, the majority of patients also receive corticosteroid therapy (48).
Histologic Features
The histopathologic hallmark of RB-ILD is the intraluminal accumulation of pigmented macrophages centered around the respiratory bronchioles (Fig 17) (49). Mild peribronchiolar inflammation and fibrosis are usually present. Findings in patients with RB-ILD cannot be differentiated histologically from those seen in asymptomatic patients with respiratory bronchiolitis.
View larger version (140K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 17. Histologic features of RB-ILD. Photomicrograph (original magnification, x100; hematoxylin-eosin stain) shows pigmented alveolar macrophages in a terminal bronchiole and the adjacent alveoli (arrows). Moderate peribronchiolar inflammation and fibrosis are present (arrowhead).
|
|
Imaging Features
The chest radiograph is insensitive for detection of RB-ILD and is often normal. Sometimes, bronchial wall thickening or reticular opacities can be seen (3,50).
The distribution at high-resolution CT is mostly diffuse (Fig 18) (46). The key high-resolution CT features of RB-ILD are centrilobular nodules in combination with ground-glass opacities and bronchial wall thickening (Fig 19) (47). The ground-glass opacities have been shown to correlate with macrophage accumulation in alveolar ducts and alveolar spaces (51). The centrilobular nodules are presumably caused by the peribronchial distribution of the intraluminal infiltrates (52). Coexisting moderate centrilobular emphysema is common, given that most patients have a smoking history.
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 18a. Distribution (a), CT image (b), and CT pattern (c) of RB-ILD. RB-ILD has an upper lung predominance (red area in a). CT shows ground-glass opacity (gray area in c) and centrilobular nodules (red areas in c).
|
|
View larger version (104K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 18b. Distribution (a), CT image (b), and CT pattern (c) of RB-ILD. RB-ILD has an upper lung predominance (red area in a). CT shows ground-glass opacity (gray area in c) and centrilobular nodules (red areas in c).
|
|
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 18c. Distribution (a), CT image (b), and CT pattern (c) of RB-ILD. RB-ILD has an upper lung predominance (red area in a). CT shows ground-glass opacity (gray area in c) and centrilobular nodules (red areas in c).
|
|
View larger version (116K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 19. RB-ILD in a 44-year-old woman with a 20 pack-year smoking history. High-resolution CT image of the upper lung lobes shows centrilobular nodules (white arrows) and patchy ground-glass opacities (black arrow). Mild coexisting centrilobular emphysema is seen (arrowhead).
|
|
|
Desquamative Interstitial Pneumonia
|
|---|
DIP is strongly associated with cigarette smoking and is considered to represent the end of a spectrum of RB-ILD. However, DIP also occurs in nonsmokers and has been related to a variety of conditions, including lung infections and exposure to organic dust (53,54).
Clinical Features
For the majority of patients with DIP, the onset of symptoms is between 30 and 40 years of age. Men are affected about twice as often as women, and most patients are current or past smokers (average smoking history of 18 pack-years) (47).
With smoking cessation and corticosteroid therapy, the prognosis is good. Nevertheless, progressive disease with eventual death can occur, notably in patients with continued cigarette smoking (48).
Histologic Features
The major histopathologic feature of DIP is the accumulation of pigmented macrophages and a few desquamated alveolar epithelial cells in the alveoli (Fig 20). As opposed to the bronchiolocentric distribution in RB-ILD, lung involvement in DIP is more diffuse and uniform (55). Usually, there is mild fibrosis in the interstitium. The more common DIP-like lung alterations seen in patients secondary to exposure to organic dust or in association with other IIPs, such as UIP, cannot be differentiated histologically from idiopathic DIP (56).
View larger version (163K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 20. Histologic features of DIP. Photomicrograph (original magnification, x200; hematoxylin-eosin stain) shows diffuse filling of the alveolar spaces with alveolar macrophages and a few desquamated alveolar epithelial cells (arrow) (inset). Mild interstitial fibrosis is present (arrowhead).
|
|
Imaging Features
Chest radiographs of DIP are nonspecific and may reveal hazy opacities (57).
At high-resolution CT, DIP is characterized by diffuse ground-glass opacities, which correlate histologically with the spatially homogeneous intraalveolar accumulation of macrophages and thickening of alveolar septa (Fig 21) (58). Usually, there is a peripheral and lower lung lobe predominance (Fig 22) (59). Other frequent CT findings include spatially limited irregular linear opacities and small cystic spaces, which are indicative of fibrotic changes (Fig 23) (3).
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 21a. Distribution (a), CT image (b), and CT pattern (c) of DIP. DIP has a peripheral predominance (red areas in a). CT shows ground-glass opacity (gray area in c), irregular linear opacities (blue areas in c), and cysts (green areas in c).
|
|
View larger version (98K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 21b. Distribution (a), CT image (b), and CT pattern (c) of DIP. DIP has a peripheral predominance (red areas in a). CT shows ground-glass opacity (gray area in c), irregular linear opacities (blue areas in c), and cysts (green areas in c).
|
|
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 21c. Distribution (a), CT image (b), and CT pattern (c) of DIP. DIP has a peripheral predominance (red areas in a). CT shows ground-glass opacity (gray area in c), irregular linear opacities (blue areas in c), and cysts (green areas in c).
|
|
View larger version (161K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 22. DIP in a 55-year-old man. High-resolution CT image of the lower lung lobes shows extensive bilateral ground-glass opacities (arrowhead). Coexisting moderate bronchial wall thickening is present (arrow).
|
|
View larger version (159K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 23. DIP in a 43-year-old man with a history of smoking. High-resolution CT image of the lower lung zones shows patchy ground-glass opacities in both lungs, predominantly in the subpleural region (arrowheads). Small cystic spaces are present in these areas (arrow).
|
|
Despite differences in the CT appearance of RB-ILD and DIP, imaging findings may overlap and may be indistinguishable from each other. To improve diagnostic accuracy, lung biopsy is required in all cases of suspected RB-ILD or DIP (3).
|
Lymphoid Interstitial Pneumonia
|
|---|
As an idiopathic disease, LIP is exceedingly rare. It is far more common as a secondary disease in association with systemic disorders, most notably Sjögren syndrome, human immunodeficiency virus infection, and variable immunodeficiency syndromes (60).
Clinical Features
LIP is more common in women than in men, and patients are usually in their fifth decade of life at presentation. They present with slowly progressive dyspnea and cough over a period of 3 or more years (3). Occasionally, patients report systemic symptoms, such as fever, night sweats, and weight loss. In the past, LIP was considered a pulmonary lymphoproliferative disorder, with subsequent progression to malignant lymphoma (
Top
Abstract
LEARNING OBJECTIVES FOR TEST...
